Abstract
Chemokines are small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors on the plasma membrane of target cells. They are also the major regulators of cell trafficking. Chemokines and their receptors were initially associated with the trafficking of leukocytes during physiological immune surveillance and with inflammatory cell recruitment in different diseases. CXCL 12, an alpha-chemokine that binds to G-protein-coupled CXCR4, plays an important and unique role in the regulation of stem/progenitor cell trafficking. Since CXCR4 is expressed on several tumor cells, these CXCR4-positive tumor cells may metastasize to organs that secrete/express CXCL12. In the specific case of gliomas, recent data show that CXCR4 and CXCL12 mRNAs colocalize to glioblastomas and that their expression increases with tumor grade and is associated with regions of necrosis and angiogenesis. This chapter summarises our current knowledge regarding the role of the CXCL12/CXCR4 axis in the central nervous system, focusing on the molecular mechanism by which the CXCL12/CXCR4 axis functions in the accelerated growth of glioblastomas, and further introduces the potential role of CXCL12/CXCR4-targeting compounds for the treatment of glioblastomas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G (2001) Stromal cell-derived factor-1 alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases ½ pathway. J Neurochem 77:1226–1236
Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G (2003) Stromal cell-derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinase ½ and Akt1. Cancer Res 63:1969–1974
Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397–405
Burger JA, Bürkle A (2007) The CXCR4 chemokine receptor in acute and chronic leukeamia: a marrow homing receptor and potential therapeutic target. Br J Haematol 137:288–296
Ehtesham M, Mapara. KY, Stevenson CB, Thompson RC (2009) CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 274:305–312
Jiang Y, Wu X-H, Shi B, Wu W-X, Yin G-R (2006) Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103:226–233
Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2006) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer, Lyon, pp 33–52
Komatani H, Sugita Y, Arakawa F, Ohshima K, Shigemori M (2009) Expression of CXCL12 on psuedopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 34:665–672
Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, Zou W (2005) CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65:465–472
Kucia M, Jankowski. K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) CXCR4-SDF1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245
Lazarini F, Than TN, Casanoa P, Arenzana-Seisdedos F, Dubois-Dalcq M (2003) Role of the alpha-chemokine stromal cell-derived factor (SDF1) in the developing and mature central nervous system. Glia 42:139–148
Li M, Ransohoff RM (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84:116–131
Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, Shim H (2007) CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through akt signaling pathway. Biochem Biophys Res Commun 359:716–722
Liu XS, Chopp M, Santra M, Hozeska-Solgot A, Zhang RL, Wang L, Teng H, Lu M, Zhang ZG (2008) Functional response to SDF1 alpha through over-expression of CXCR4 on adult subventricular zone progenitor cells. Brain Res 1226:18–26
Luo Y, Iathia J, Mughal M, Mattson MP (2008) SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J Biol Chem 283:24789–24800
Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM, Held-Feindt J (2008) Expression of stem cell markers in human astrocytomas of different WHO grades. J Nerooncol 86:31–45
Maderna E, Salmaggi A, Calatozzolo C, Limido L, Pollo B (2007) Nestin, PDGFRbeta, CXCL12, and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and May provide prognostic information. Cancer Biol Ther 6:1018–1024
Matsuo Y, Ochi N, Sawai M, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S (2009) CXCL8/IL-8 and CXCL12/SDF-1 alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 124:853–861
Oh JW, Olman M, Benveniste EN (2009) CXCL12-mediated induction of plasminogen activator inhibitor-1 expression in human CXCR4 positive astroglioma cells. Biol Pharm Bull 32:573–577
Ping YF, Yao XH, Chen JH, Liu H, Chen DL, Zhou XD, Wang JM, Bian XW (2007) The anti-cancer compound nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells. J Neurooncol 84:21–29
Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES (2008) Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing’s sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer 123:831–837
Redjal N, Chan JA, Segal RA, Kung AL (2006) CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 12:6765–6771
Rempel SA, Dudas S, Ge S, Gutiérrez JA (2000) Identification and localization of cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6:102–111
Rubin JB, Kung AL, Klein R,S, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster ad, Segal RA (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100:13513–13518
Schönemeier B, Schulz S, Hoellt V, Stumm R (2008) Enhanced expression of the CXCL12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J Neuroimmunol 198:39–45
Singh, S,, Singh, P,, Grizzle, WE,and, Lillard JW Jr. (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84:1666–1676
Smith JR, Faikenhagen KM, Coupland SE, Chipps TJ, Rosenblum JT (2007) Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol 127:633–641
Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Hőllt V, Schulz S (2002) A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22:5865–5878
Sugita Y, Nakamura Y, Yamamoto M, Oda E, Tokunaga O, Shigemori M (2005) Expression of tubulin beta II in neuroepithelial tumors: reflection of architectural changes in the developing human brain. Acta Neuropathol 110:127–134
Yang SX, Chen JH, Jiang XF, Wang QL, Chen ZQ, Zhao W, Feng Y-H, Xin R, Shi J-Q, Bian X-W (2005) Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Commun 335:523–528
Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB (2007) Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res 67:651–658
Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Yamamoto A, Yamamoto H, Miyado K, Okano HJ, Fukagawa R, Higaki K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I (2006) Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181–2187
Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW (2008) Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Schere’s structures. Am J Pathol 173:545–560
Zagzag D, Lukyanov Y, Lan Li, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221–1232
Zhang J, Sarkar S, Yong VW (2005) The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26:2069–2077
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Sugita, Y. (2011). Glioblastomas: Role of CXCL12 Chemokine. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 1. Tumors of the Central Nervous System, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0344-5_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-0344-5_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0343-8
Online ISBN: 978-94-007-0344-5
eBook Packages: MedicineMedicine (R0)